12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BioChaperone insulin combo: Phase I/II started

Adocia began a double-blind, crossover, German Phase I/II trial to compare a version of Lantus insulin glargine that uses Adocia's BioChaperone polymer technology in combination with Humalog insulin lispro vs. Humalog Mix insulin lispro/insulin lispro protamine...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >